Display Settings:

Format

Send to:

Choose Destination
    Brain. 2009 Nov;132(Pt 11):3165-74. Epub 2009 Aug 31.

    Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy.

    Source

    Mitochondrial Research Group, Institute for Ageing and Health, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK. rita.horvath@ncl.ac.uk

    Abstract

    Childhood-onset mitochondrial encephalomyopathies are usually severe, relentlessly progressive conditions that have a fatal outcome. However, a puzzling infantile disorder, long known as 'benign cytochrome c oxidase deficiency myopathy' is an exception because it shows spontaneous recovery if infants survive the first months of life. Current investigations cannot distinguish those with a good prognosis from those with terminal disease, making it very difficult to decide when to continue intensive supportive care. Here we define the principal molecular basis of the disorder by identifying a maternally inherited, homoplasmic m.14674T>C mt-tRNA(Glu) mutation in 17 patients from 12 families. Our results provide functional evidence for the pathogenicity of the mutation and show that tissue-specific mechanisms downstream of tRNA(Glu) may explain the spontaneous recovery. This study provides the rationale for a simple genetic test to identify infants with mitochondrial myopathy and good prognosis.

    PMID:
    19720722
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2768660
    Free PMC Article

    Images from this publication.See all images (4) Free text

    Figure 1
    Figure 3
    Figure 2
    Figure 4

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk